Bone metastasis treatment modeling via optimal control.


Journal

Journal of mathematical biology
ISSN: 1432-1416
Titre abrégé: J Math Biol
Pays: Germany
ID NLM: 7502105

Informations de publication

Date de publication:
01 2019
Historique:
received: 22 11 2017
revised: 29 07 2018
pubmed: 23 8 2018
medline: 23 6 2020
entrez: 23 8 2018
Statut: ppublish

Résumé

Metastatic disease is a lethal stage of cancer progression. It is characterized by the spread of aberrant cells from a primary tumor to distant tissues like the bone. Several treatments are used to deal with bone metastases formation, but they are palliative since the disease is considered incurable. Computational and mathematical models are used to understand the underlying mechanisms of how bone metastasis evolves. In this way, new therapies aiming to reduce or eliminate the metastatic burden in the bone tissue may be proposed. We present an optimal control approach to analyze some common treatments for bone metastasis. In particular, we focus on denosumab treatment, an anti-resorptive therapy, and radiotherapy treatment which has a cell killing action. We base our work in a variant of an existing model introduced by Komarova. The new model incorporates a logistic equation in order to describe the bone metastasis evolution. We provide proofs of existence and uniqueness of solutions to the corresponding optimal control problems for each treatment. Moreover, we present some numerical simulations to analyze the effectiveness of both treatments when different interactions between cancer and bone cells occur. A discussion of the obtained results is provided.

Identifiants

pubmed: 30132065
doi: 10.1007/s00285-018-1281-3
pii: 10.1007/s00285-018-1281-3
doi:

Substances chimiques

Bone Density Conservation Agents 0
Denosumab 4EQZ6YO2HI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-526

Références

Math Biosci. 2017 Dec;294:1-14
pubmed: 28919575
J Math Biol. 2017 Dec;75(6-7):1693-1713
pubmed: 28484801
Math Biosci. 1990 Oct;101(2):237-84
pubmed: 2134485
Eur J Cancer. 2016 Jan;53:75-83
pubmed: 26693901
Cancer Control. 2012 Apr;19(2):92-101
pubmed: 22487971
Semin Radiat Oncol. 2008 Oct;18(4):234-9
pubmed: 18725109
J Theor Biol. 2016 Feb 21;391:1-12
pubmed: 26657065
J Theor Biol. 2004 Aug 7;229(3):293-309
pubmed: 15234198
PLoS One. 2011;6(11):e27494
pubmed: 22110661
Bone. 2008 Aug;43(2):249-63
pubmed: 18514606
Nat Rev Cancer. 2002 Aug;2(8):584-93
pubmed: 12154351
Oncotarget. 2017 Sep 23;8(49):86447-86462
pubmed: 29156807
Biol Direct. 2010 Apr 20;5:28
pubmed: 20406449
Math Biosci Eng. 2012 Apr;9(2):281-95
pubmed: 22901065
Lancet Oncol. 2014 Feb;15(2):164-71
pubmed: 24369114
Br J Cancer. 2009 Oct 6;101(7):1130-6
pubmed: 19724279
Bone. 2003 Aug;33(2):206-15
pubmed: 14499354
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
Int J Dev Biol. 2004;48(5-6):599-606
pubmed: 15349834
Connect Tissue Res. 2018 Nov;59(6):509-522
pubmed: 29448860
J Bone Oncol. 2016 Apr 13;5(3):124-127
pubmed: 27761372
Math Biosci. 2018 May;299:153-164
pubmed: 29526549
J Orthop Res. 2015 Mar;33(3):334-42
pubmed: 25408493
Pract Radiat Oncol. 2017 Jan - Feb;7(1):4-12
pubmed: 27663933
Math Biosci. 2017 Aug;290:9-21
pubmed: 28576678
Math Biosci. 2017 Apr;286:58-64
pubmed: 28189632
Comput Methods Biomech Biomed Engin. 2012;15(4):333-46
pubmed: 21264782
Bull Math Biol. 2017 Jan;79(1):117-142
pubmed: 27905067
Curr Osteoporos Rep. 2017 Aug;15(4):247-254
pubmed: 28646444
Nat Rev Cancer. 2015 Jul;15(7):409-25
pubmed: 26105538
Cancer Res. 2014 May 1;74(9):2391-401
pubmed: 24788098
PLoS Comput Biol. 2012;8(10):e1002703
pubmed: 23093918
Radiother Oncol. 2017 Jul;124(1):38-44
pubmed: 28629871
Math Biosci. 2015 Jun;264:29-37
pubmed: 25784536
Biomed Res Int. 2015;2015:421746
pubmed: 26247020

Auteurs

Ariel Camacho (A)

CIMAT, 36000, Guanajuato, Gto., Mexico.

Silvia Jerez (S)

CIMAT, 36000, Guanajuato, Gto., Mexico. jerez@cimat.mx.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH